Joined December 2012
2,134 Photos and videos
A system for AI guided remote initiation, titration, and monitoring of GDMT ➡️ 📈 Improved GDMT composite score ⏱️ Timely dose optimization ⚖️ High rates of recommendations being acted on ❤️‍🩹 Associated with ⬇️ HF 🏨s Usual Care Minimal improvement doi.org/10.1016/j.jchf.2025.…
1
8
15
731
Gregg Fonarow MD retweeted
Groundbreaking results from the TEAM-HF ✅ 4-drug GDMT use jumped from 21% → 88% in the GDMT Clinic (4.2× increase) ✅ Optimized in ~16 weeks (3–6 visits) ✅ 76% still on 4-drug GDMT at 6-month follow-up Vs. usual care: 0.0× increase 😬
8
12
820
Gregg Fonarow MD retweeted
Quadruple guideline-directed medical therapy in #HeartFailure with reduced ejection fraction was projected to offset hospitalization costs by nearly $10 000 per patient-year, frequently yielding net health care savings. ja.ma/4vJj9Z8
1
11
18
1,737
GDMT focused outpatient clinics can rapidly, safely, and efficiently ➡️ ✅ 88% quadruple GDMT use 🎯 dosing ⤴️ 📈 adherence ⤴️ ❤️‍🩹 rapid clinical benefits Routine care at one the most renowned health systems ➡️ 😱 1% quadruple GDMT use Stunning! doi.org/10.1016/j.jchf.2024.…
1
8
17
1,213
Quadruple GDMT can be simultaneously initiated rapidly uptitrated in ambulatory outpatients ✅ Time to quadruple GDMT optimization 29 days ✅ Safe, well tolerated, efficient Benefits: ☠️ ⬇️ RR 72.9% 🏥 HF ⬇️ RR 85% Extend survival 7-11 years At a 💊 cost of only ~1 a day
1
11
21
1,630
😱 US #HeartFailure mortality is still going ⤴️⤴️⤴️ 💔 425,147 HF related ☠️ (45% of all CV ☠️) in 2023 🆘 Yet, massive gaps in GDMT use and HF prevention efforts Fight back: 🎯 Prevention 🎯Treatment 🎯 Implementation NOW #Cardiology #GDMT @ACCinTouch @American_Heart @HFSA
2
10
23
1,375
Despite full access to quadruple GDMT at no or very low out of pocket cost….. Fewer than one in four patients with HFrEF received quadruple GDMT over 2.9 years of follow-up Vital need to improve care and outcomes for HFrEF
Among US veterans with #HeartFailure with reduced ejection fraction, fewer than one-quarter achieved quadruple guideline-directed medical therapy within 2.9 years, and medication copays were associated with lower rates of therapy achievement. ja.ma/4ekr9Jf
3
1
15
1,248
💔 Suboptimal uptake of pharmacological treatments in newly diagnosed patients with HF ➡️ Poor prognosis 🎯 Critical to improve implementation of evidence-based therapies within each LVEF subtype nature.com/articles/s41598-0…
3
7
626
Would ~$1 a day in medication cost for HFrEF be considered of sufficient value if it resulted in an average of $26 to $63 a day in reduced healthcare expenditures? @HFSA @ACCinTouch @American_Heart @AAHFN @JAMACardio jamanetwork.com/journals/jam…
1
2
9
611
❤️‍🩹 HFrEF 💊 ARNI BB MRA SGLT2i 🚀 Ultrafast clinical benefits ☠️ ⬇️⬇️⬇️⬇️ 🏨 ⬇️⬇️⬇️⬇️ ⚖️ HRQOL ⤴️ 🪎 Amazing value 🆘 < 2 in 10 eligible treated ❌ Delaying/omitting quadruple GDMT causes preventable ☠️s, 🏨s, and financial toxicity
1
6
9
810
Gregg Fonarow MD retweeted
New data: Switching HFrEF patients from no therapy fully generic optimal GDMT cuts projected hospitalization costs by $22,549 (58%) per patient per year. Even from today’s partial care, full optimization saves $6,240–$8,556/patient/year. Quadruple therapy works
7
17
1,153
Gregg Fonarow MD retweeted
Optimal GDMT doesn’t just save lives — it saves money across every hospitalization category. Mean 1-year costs vs. No GDMT: All-cause hosp: $39K → $15K HF hosp: $17K → $2K CV hosp: $28K → $4K Total (Parts A B): $56K → $32K Even partial GDMT costs MORE than optimal
8
11
780
Gregg Fonarow MD retweeted
Lower prices could make the value of quadruple GDMT even more compelling 💊📉 At current Cost Plus Drugs cash prices, generic/priced options for HFrEF therapy may cost ~$31/month , about $380/year. This could further amplify the hospitalization cost-offset of optimal GDMT. @gcfmd @SJGreene_md
Quadruple guideline-directed medical therapy in #HeartFailure with reduced ejection fraction was projected to offset hospitalization costs by nearly $10 000 per patient-year, frequently yielding net health care savings. ja.ma/4eyMQ9I
1
4
16
2,873
Gregg Fonarow MD retweeted
Quadruple guideline-directed medical therapy in #HeartFailure with reduced ejection fraction was projected to offset hospitalization costs by nearly $10 000 per patient-year, frequently yielding net health care savings. ja.ma/4eyMQ9I
1
12
29
4,633
Now available at a monthly cost of only $14.40
AAHFN In the Know A decade of real-world experience with sacubitril/valsartan (Sac/Val) continues to reinforce what clinical trials first revealed: Sac/Val remains a cornerstone therapy for patients with HFrEF. Read more: doi.org/10.1093/eschf/xvag09…
1
12
23
3,134
Gregg Fonarow MD retweeted
Quadruple GDMT for HFrEF at generic pricing costs just $380/year. 📉 vs partial GDMT (2 drugs): saves ~$9,400/patient/year 📉 vs no therapy: saves ~$23,400/patient/year That’s a 26–63× return on every dollar spent on meds Barriers to prescribing GDMT are running out of excuses.
6
19
1,145